SlideShare una empresa de Scribd logo
1 de 24
Descargar para leer sin conexión
Introduction to Cancer Genomics
Eva Yap, MSc. Student
Experimental Medicine Graduate Program, BC Cancer Research Centre
February 25, 2016
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 1 / 24
Overview
1 Genetic Variations in Oncogenesis
2 Genomics-driven Era of Cancer Research
3 Summary
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 2 / 24
Overview
1 Genetic Variations in Oncogenesis
2 Genomics-driven Era of Cancer Research
3 Summary
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 3 / 24
Cancer is an (epi)genetic disease
Proto-oncogenes - stimulate proliferation, inhibit differentiation and
apoptosis
Tumour suppressors - inhibit proliferation, stimulate differentiation
and apoptosis
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 4 / 24
Cancer is an (epi)genetic disease
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 5 / 24
Inherited vs. Acquired
Knudson’s two hit hypothesis, loss of heterozygosity
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 6 / 24
Driver vs. Passenger Mutations
Driver mutations confer growth advantage on the cancer cell
Passenger mutations has no functional consequences and occur
during cell division
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 7 / 24
Hallmarks of Cancer
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 8 / 24
Hallmarks of Cancer
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 9 / 24
Types of Mutations
Single nucleotide variants (SNVs)
Structural variants (SVs)
Copy number variations (CNVs)
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 10 / 24
Vogelgram and Malignant Transformation of a Polyp
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 11 / 24
The Philadelphia Chromosome
BCR-ABL1 transcript codes for a fusion protein that is always on, thereby
causing unregulated cell division.
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 12 / 24
EGFR Copy Number Amplification in Lung Cancer
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 13 / 24
Overview
1 Genetic Variations in Oncogenesis
2 Genomics-driven Era of Cancer Research
3 Summary
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 14 / 24
A Milestone for Genomics
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 15 / 24
A Milestone for Genomics
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 16 / 24
NGS Workflow
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 17 / 24
Different Types of NGS Methods
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 18 / 24
Example of a variant calling pipeline
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 19 / 24
Not a one-size-fits-all solution
Cancer treatments: surgery, radiation, chemotherapy
Two types of cancers (e.g. eye vs. colorectal vs. blood vs. lung) can
be driven by distinct mutations
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 20 / 24
Interpatient Heterogeneity
In fact, within the same type of cancer, interpatient heterogeneity exists!
Lung Adenocarcinoma - 230 samples (TCGA, Nature 2014)
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 21 / 24
Targeted therapy
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 22 / 24
Overview
1 Genetic Variations in Oncogenesis
2 Genomics-driven Era of Cancer Research
3 Summary
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 23 / 24
Take-home messages
Cancer can be driven by various types of genetic mutations
Advancement in genomics can improve our understanding of cancer
biology leading to better patient management and therapeutic
strategy
Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 24 / 24

Más contenido relacionado

La actualidad más candente

Nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma ...
Nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma  ...Nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma  ...
Nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma ...Sanda Morar
 
CCRC Clonality Poster
CCRC Clonality PosterCCRC Clonality Poster
CCRC Clonality PosterNathan How
 
CRC Immunotherapy Call-on Congress 2017 Al Benson
CRC Immunotherapy Call-on Congress  2017 Al BensonCRC Immunotherapy Call-on Congress  2017 Al Benson
CRC Immunotherapy Call-on Congress 2017 Al BensonFight Colorectal Cancer
 
Viviane Muniz CV 2016
Viviane Muniz CV 2016Viviane Muniz CV 2016
Viviane Muniz CV 2016Viviane Muniz
 
DDW Biomarkers of Polyp Recurrence in Colon Cancer Patients
DDW Biomarkers of Polyp Recurrence in Colon Cancer PatientsDDW Biomarkers of Polyp Recurrence in Colon Cancer Patients
DDW Biomarkers of Polyp Recurrence in Colon Cancer PatientsSean Maden
 
HUMAN PAPILLOMAVIRUS IS A NECESSARY CAUSE OF INVASIVE CERVICAL CANCER WORLD-WIDE
HUMAN PAPILLOMAVIRUS IS A NECESSARY CAUSE OF INVASIVE CERVICAL CANCER WORLD-WIDEHUMAN PAPILLOMAVIRUS IS A NECESSARY CAUSE OF INVASIVE CERVICAL CANCER WORLD-WIDE
HUMAN PAPILLOMAVIRUS IS A NECESSARY CAUSE OF INVASIVE CERVICAL CANCER WORLD-WIDEAlberto Cuadrado
 
Donna_Badgwell_2016_Curriculum_Vitae
Donna_Badgwell_2016_Curriculum_VitaeDonna_Badgwell_2016_Curriculum_Vitae
Donna_Badgwell_2016_Curriculum_VitaeDonna Badgwell
 
Senology Newsletter - April 23, 2015
Senology Newsletter - April 23, 2015Senology Newsletter - April 23, 2015
Senology Newsletter - April 23, 2015Senology.org
 
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of SenologySenology.org
 
Senology Newsletter - January 27, 2015
Senology Newsletter - January 27, 2015Senology Newsletter - January 27, 2015
Senology Newsletter - January 27, 2015Senology.org
 
Senology Newsletter - December 3, 2014
Senology Newsletter - December 3, 2014Senology Newsletter - December 3, 2014
Senology Newsletter - December 3, 2014Senology.org
 
9780387884400 fm
9780387884400 fm9780387884400 fm
9780387884400 fmcarlos_wil
 

La actualidad más candente (18)

Nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma ...
Nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma  ...Nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma  ...
Nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma ...
 
CCRC Clonality Poster
CCRC Clonality PosterCCRC Clonality Poster
CCRC Clonality Poster
 
CRC Immunotherapy Call-on Congress 2017 Al Benson
CRC Immunotherapy Call-on Congress  2017 Al BensonCRC Immunotherapy Call-on Congress  2017 Al Benson
CRC Immunotherapy Call-on Congress 2017 Al Benson
 
Mdp051v1
Mdp051v1Mdp051v1
Mdp051v1
 
Viviane Muniz CV 2016
Viviane Muniz CV 2016Viviane Muniz CV 2016
Viviane Muniz CV 2016
 
kong l FCV
kong l FCVkong l FCV
kong l FCV
 
Ortiz CV 12.15.16
Ortiz CV 12.15.16Ortiz CV 12.15.16
Ortiz CV 12.15.16
 
s12935-014-0115-7
s12935-014-0115-7s12935-014-0115-7
s12935-014-0115-7
 
DDW Biomarkers of Polyp Recurrence in Colon Cancer Patients
DDW Biomarkers of Polyp Recurrence in Colon Cancer PatientsDDW Biomarkers of Polyp Recurrence in Colon Cancer Patients
DDW Biomarkers of Polyp Recurrence in Colon Cancer Patients
 
HUMAN PAPILLOMAVIRUS IS A NECESSARY CAUSE OF INVASIVE CERVICAL CANCER WORLD-WIDE
HUMAN PAPILLOMAVIRUS IS A NECESSARY CAUSE OF INVASIVE CERVICAL CANCER WORLD-WIDEHUMAN PAPILLOMAVIRUS IS A NECESSARY CAUSE OF INVASIVE CERVICAL CANCER WORLD-WIDE
HUMAN PAPILLOMAVIRUS IS A NECESSARY CAUSE OF INVASIVE CERVICAL CANCER WORLD-WIDE
 
Wilmarie reflection 3 final
Wilmarie reflection 3 finalWilmarie reflection 3 final
Wilmarie reflection 3 final
 
Donna_Badgwell_2016_Curriculum_Vitae
Donna_Badgwell_2016_Curriculum_VitaeDonna_Badgwell_2016_Curriculum_Vitae
Donna_Badgwell_2016_Curriculum_Vitae
 
Senology Newsletter - April 23, 2015
Senology Newsletter - April 23, 2015Senology Newsletter - April 23, 2015
Senology Newsletter - April 23, 2015
 
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
1th Meet the Professor - Sept 10-12, 2015, Padua - with Patronage of Senology
 
Senology Newsletter - January 27, 2015
Senology Newsletter - January 27, 2015Senology Newsletter - January 27, 2015
Senology Newsletter - January 27, 2015
 
Senology Newsletter - December 3, 2014
Senology Newsletter - December 3, 2014Senology Newsletter - December 3, 2014
Senology Newsletter - December 3, 2014
 
9780387884400 fm
9780387884400 fm9780387884400 fm
9780387884400 fm
 
Journal of Cancer Science & Research
Journal of Cancer Science & ResearchJournal of Cancer Science & Research
Journal of Cancer Science & Research
 

Destacado (14)

Neoplasia Clincial effects and Spread of cancer
Neoplasia Clincial effects and Spread of cancerNeoplasia Clincial effects and Spread of cancer
Neoplasia Clincial effects and Spread of cancer
 
Molecular Basis of Cancer
 Molecular Basis of Cancer Molecular Basis of Cancer
Molecular Basis of Cancer
 
Factores carcinogenicos
Factores carcinogenicosFactores carcinogenicos
Factores carcinogenicos
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
An Overview of Cancer Genetics
An Overview of Cancer GeneticsAn Overview of Cancer Genetics
An Overview of Cancer Genetics
 
Molecular basis of Cancer
Molecular basis of CancerMolecular basis of Cancer
Molecular basis of Cancer
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
carcinogenesis-
carcinogenesis-carcinogenesis-
carcinogenesis-
 
Carcinogenesis (2)
Carcinogenesis (2)Carcinogenesis (2)
Carcinogenesis (2)
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Introduction cancer genetics and genomics
Introduction cancer genetics and genomicsIntroduction cancer genetics and genomics
Introduction cancer genetics and genomics
 

Similar a quest_intro_cancer_genomics

Protocol for the Treatment Prostate Cancer - Dr Serge Jurasunas
Protocol for the Treatment Prostate Cancer - Dr Serge JurasunasProtocol for the Treatment Prostate Cancer - Dr Serge Jurasunas
Protocol for the Treatment Prostate Cancer - Dr Serge JurasunasSheldon Stein
 
Understanding Lynch Syndrome
Understanding Lynch SyndromeUnderstanding Lynch Syndrome
Understanding Lynch Syndromebkling
 
Question of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer MedicineQuestion of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer MedicineHCA Healthcare UK
 
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...UCLA
 
Workshop with the Experts: Colorectal Cancer Series
Workshop with the Experts: Colorectal Cancer SeriesWorkshop with the Experts: Colorectal Cancer Series
Workshop with the Experts: Colorectal Cancer SeriesClinical Care Options
 
What is role of pathologist
What is role of pathologistWhat is role of pathologist
What is role of pathologistAnjen Chenn
 
Owen Patrick Smith , Prof of Haematology, Trinity College Dublin
Owen Patrick Smith , Prof of Haematology, Trinity College DublinOwen Patrick Smith , Prof of Haematology, Trinity College Dublin
Owen Patrick Smith , Prof of Haematology, Trinity College DublinInvestnet
 
Genetics and "Genomics" Dr. Roisin O’Cearbhaill slides
Genetics and "Genomics" Dr. Roisin O’Cearbhaill slidesGenetics and "Genomics" Dr. Roisin O’Cearbhaill slides
Genetics and "Genomics" Dr. Roisin O’Cearbhaill slidesbkling
 
TUMOR MARKERS OF COLORECTAL CARCINOMA
TUMOR MARKERS OF  COLORECTAL CARCINOMATUMOR MARKERS OF  COLORECTAL CARCINOMA
TUMOR MARKERS OF COLORECTAL CARCINOMAMoustafa Rezk
 
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...UCLA
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 

Similar a quest_intro_cancer_genomics (20)

Protocol for the Treatment Prostate Cancer - Dr Serge Jurasunas
Protocol for the Treatment Prostate Cancer - Dr Serge JurasunasProtocol for the Treatment Prostate Cancer - Dr Serge Jurasunas
Protocol for the Treatment Prostate Cancer - Dr Serge Jurasunas
 
Understanding Lynch Syndrome
Understanding Lynch SyndromeUnderstanding Lynch Syndrome
Understanding Lynch Syndrome
 
Dna replication
Dna replication Dna replication
Dna replication
 
Dna replication 2
Dna replication 2Dna replication 2
Dna replication 2
 
Cancer clinic
Cancer clinicCancer clinic
Cancer clinic
 
DNA replication
DNA replication DNA replication
DNA replication
 
#HCAQofQ Tariq Mughal
#HCAQofQ Tariq Mughal#HCAQofQ Tariq Mughal
#HCAQofQ Tariq Mughal
 
Question of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer MedicineQuestion of Quality Conference 2016 - Personalized Cancer Medicine
Question of Quality Conference 2016 - Personalized Cancer Medicine
 
Liquid biopsies
Liquid biopsiesLiquid biopsies
Liquid biopsies
 
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
 
2015 fellows lecture version d
2015 fellows lecture version d2015 fellows lecture version d
2015 fellows lecture version d
 
Workshop with the Experts: Colorectal Cancer Series
Workshop with the Experts: Colorectal Cancer SeriesWorkshop with the Experts: Colorectal Cancer Series
Workshop with the Experts: Colorectal Cancer Series
 
What is role of pathologist
What is role of pathologistWhat is role of pathologist
What is role of pathologist
 
Endometrial cancer
Endometrial cancerEndometrial cancer
Endometrial cancer
 
Owen Patrick Smith , Prof of Haematology, Trinity College Dublin
Owen Patrick Smith , Prof of Haematology, Trinity College DublinOwen Patrick Smith , Prof of Haematology, Trinity College Dublin
Owen Patrick Smith , Prof of Haematology, Trinity College Dublin
 
Genetics and "Genomics" Dr. Roisin O’Cearbhaill slides
Genetics and "Genomics" Dr. Roisin O’Cearbhaill slidesGenetics and "Genomics" Dr. Roisin O’Cearbhaill slides
Genetics and "Genomics" Dr. Roisin O’Cearbhaill slides
 
TUMOR MARKERS OF COLORECTAL CARCINOMA
TUMOR MARKERS OF  COLORECTAL CARCINOMATUMOR MARKERS OF  COLORECTAL CARCINOMA
TUMOR MARKERS OF COLORECTAL CARCINOMA
 
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...
 
CVBPak7.27.15
CVBPak7.27.15CVBPak7.27.15
CVBPak7.27.15
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 

quest_intro_cancer_genomics

  • 1. Introduction to Cancer Genomics Eva Yap, MSc. Student Experimental Medicine Graduate Program, BC Cancer Research Centre February 25, 2016 Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 1 / 24
  • 2. Overview 1 Genetic Variations in Oncogenesis 2 Genomics-driven Era of Cancer Research 3 Summary Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 2 / 24
  • 3. Overview 1 Genetic Variations in Oncogenesis 2 Genomics-driven Era of Cancer Research 3 Summary Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 3 / 24
  • 4. Cancer is an (epi)genetic disease Proto-oncogenes - stimulate proliferation, inhibit differentiation and apoptosis Tumour suppressors - inhibit proliferation, stimulate differentiation and apoptosis Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 4 / 24
  • 5. Cancer is an (epi)genetic disease Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 5 / 24
  • 6. Inherited vs. Acquired Knudson’s two hit hypothesis, loss of heterozygosity Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 6 / 24
  • 7. Driver vs. Passenger Mutations Driver mutations confer growth advantage on the cancer cell Passenger mutations has no functional consequences and occur during cell division Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 7 / 24
  • 8. Hallmarks of Cancer Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 8 / 24
  • 9. Hallmarks of Cancer Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 9 / 24
  • 10. Types of Mutations Single nucleotide variants (SNVs) Structural variants (SVs) Copy number variations (CNVs) Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 10 / 24
  • 11. Vogelgram and Malignant Transformation of a Polyp Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 11 / 24
  • 12. The Philadelphia Chromosome BCR-ABL1 transcript codes for a fusion protein that is always on, thereby causing unregulated cell division. Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 12 / 24
  • 13. EGFR Copy Number Amplification in Lung Cancer Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 13 / 24
  • 14. Overview 1 Genetic Variations in Oncogenesis 2 Genomics-driven Era of Cancer Research 3 Summary Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 14 / 24
  • 15. A Milestone for Genomics Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 15 / 24
  • 16. A Milestone for Genomics Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 16 / 24
  • 17. NGS Workflow Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 17 / 24
  • 18. Different Types of NGS Methods Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 18 / 24
  • 19. Example of a variant calling pipeline Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 19 / 24
  • 20. Not a one-size-fits-all solution Cancer treatments: surgery, radiation, chemotherapy Two types of cancers (e.g. eye vs. colorectal vs. blood vs. lung) can be driven by distinct mutations Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 20 / 24
  • 21. Interpatient Heterogeneity In fact, within the same type of cancer, interpatient heterogeneity exists! Lung Adenocarcinoma - 230 samples (TCGA, Nature 2014) Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 21 / 24
  • 22. Targeted therapy Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 22 / 24
  • 23. Overview 1 Genetic Variations in Oncogenesis 2 Genomics-driven Era of Cancer Research 3 Summary Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 23 / 24
  • 24. Take-home messages Cancer can be driven by various types of genetic mutations Advancement in genomics can improve our understanding of cancer biology leading to better patient management and therapeutic strategy Eva Yap, MSc. Student (Experimental Medicine Graduate Program, BC Cancer Research Centre)Introduction to Cancer Genomics February 25, 2016 24 / 24